- Home
- RLAY vs LPRO Comparison
RLAY vs LPRO Comparison
Compare RLAY & LPRO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- RLAY
- LPRO
- Stock Information
- Founded
- RLAY 2015
- LPRO 2000
- Country
- RLAY United States
- LPRO United States
- Employees
- RLAY N/A
- LPRO N/A
- Industry
- RLAY Biotechnology: Biological Products (No Diagnostic Substances)
- LPRO Finance: Consumer Services
- Sector
- RLAY Health Care
- LPRO Finance
- Exchange
- RLAY Nasdaq
- LPRO Nasdaq
- Market Cap
- RLAY 723.1M
- LPRO 712.5M
- IPO Year
- RLAY 2020
- LPRO N/A
- Fundamental
- Price
- RLAY $4.94
- LPRO $5.13
- Analyst Decision
- RLAY Strong Buy
- LPRO Buy
- Analyst Count
- RLAY 10
- LPRO 7
- Target Price
- RLAY $20.11
- LPRO $6.80
- AVG Volume (30 Days)
- RLAY 2.9M
- LPRO 282.3K
- Earning Date
- RLAY 02-20-2025
- LPRO 02-25-2025
- Dividend Yield
- RLAY N/A
- LPRO N/A
- EPS Growth
- RLAY N/A
- LPRO N/A
- EPS
- RLAY N/A
- LPRO 0.04
- Revenue
- RLAY $10,006,000.00
- LPRO $95,887,000.00
- Revenue This Year
- RLAY N/A
- LPRO N/A
- Revenue Next Year
- RLAY N/A
- LPRO $13.76
- P/E Ratio
- RLAY N/A
- LPRO $136.11
- Revenue Growth
- RLAY N/A
- LPRO N/A
- 52 Week Low
- RLAY $3.50
- LPRO $4.57
- 52 Week High
- RLAY $11.16
- LPRO $8.43
- Technical
- Relative Strength Index (RSI)
- RLAY 53.29
- LPRO 38.17
- Support Level
- RLAY $3.50
- LPRO $5.10
- Resistance Level
- RLAY $5.99
- LPRO $5.30
- Average True Range (ATR)
- RLAY 0.54
- LPRO 0.20
- MACD
- RLAY 0.06
- LPRO -0.03
- Stochastic Oscillator
- RLAY 49.40
- LPRO 10.95
About RLAY Relay Therapeutics Inc.
Relay Therapeutics Inc is a clinical-stage precision medicine company transforming the drug discovery process by combining leading-edge computational and experimental technologies with the goal of bringing life-changing therapies to patients. the Dynamo platform integrates an array of leading-edge computational and experimental approaches designed to drug-protein targets that have previously been intractable or inadequately addressed. The company is advancing a pipeline of medicine candidates to address targets in precision oncology and genetic disease, including product candidates, RLY-4008, RLY-2608, and GDC-1971 (formerly known as RLY-1971).
About LPRO Open Lending Corporation
Open Lending Corp is engaged in providing automated lending services to financial institutions. The company offers loan analytics, risk-based pricing, risk modeling, and automated decision technology. Its Lenders Protection Program ("LPP") enables automotive lenders to make loans that are largely insured against losses from defaults.